Fact CheckerSign in

NCT07468188Recruiting

Diabetes Body Project 2

Development of a T2D-Specific, Virtually-Delivered Disordered Eating Prevention Intervention - Diabetes Body Project 2

Source: ClinicalTrials.gov · Last updated 12 Mar 2026

Brief summary (registry, in English)

The purpose of this study is to test the feasibility and effectiveness of an eating disorder prevention program specifically targeted for women with type 2 diabetes (T2D) called the Diabetes Body Project 2 (DBP2). The Diabetes Body Project 2 (DBP2) will be adapted from the Diabetes Body Project, which is an eating disorder prevention program developed to improve satisfaction with body image and diabetes management for young women with type 1 diabetes (DBP). The study is looking to see if the DBP is effective in improving body image concerns, reducing disordered eating behaviors and improving glycemic control in women with T2D.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
42 (estimated)
First submitted
30 Jan 2026
Start date
24 Jan 2025
Primary completion date
28 Feb 2027
Lead sponsor
Joslin Diabetes Center
NCT number
NCT07468188

What you commit to

  • Study type: Interventional
  • Planned participants: 42
  • From 24 Jan 2025 to the primary completion date, 28 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Recent hospitalization for eating disorder within the last 12 months
  • Eating disorder related diabetic ketoacidosis within the last 12 months
  • developmental, cognitive, or psychiatric limitations that compromise participation in the intervention sessions and study.

Other

  • unwillingness to be video-recorded,
  • restricted English proficiency

Who the study is looking for

  • 1.) Female sex 2) self-reported gender identity of "woman"; 3) age 18-40 years old; 4) diagnosed with T2D for at least 6 months; 5) experiencing at least one body image concern.

Age in the registry: 18 years to 40 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Joslin Diabetes Center
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.